OpenAI 前科学负责人 Kevin Weil 创办 Warp Sciences,融资 2.15 亿美元
Former OpenAI science lead launches Warp Science to automate wet labs with robots
OpenAI 前科学负责人 Kevin Weil 宣布创办 Warp Sciences,以 8.65 亿美元估值完成 2.15 亿美元融资,通过训练机器人合成并测试研究人员筛选出的候选化合物,来推进药物发现自动化。
Former OpenAI science lead Kevin Weil has launched Warp Sciences, a new AI startup focused on automating lab work for drug discovery. The company, which trains robots to make and test promising compounds identified by researchers, has raised $215 million at an $865 million valuation, according to Weil, who announced the startup and funding on X.
The round was led by Lightspeed, with participation from IVP, Mayfield, Lux Capital, Premji Invest, and Menlo Ventures.
For years, biotech companies have outsourced the most labor-intensive work of synthesizing thousands of variations of molecules to contractors in China, such as WuXi AppTec. With Warp Sciences, Weil hopes to reshore that work and insulate the entire drug development process from geopolitical supply-chain risks.
Wearing cameras and sensor gloves, the startup’s human chemists will train robots to perform various lab tasks. By automating wet-lab work, Warp Sciences aims to accelerate drug discovery using robots that can operate around the clock.
来源:TechCrunch 生物技术 · techcrunch.com